BAJAJ BROKING

Notification
No new Notification messages
Inventurus Knowledge Solutions IPO is Open!
Apply for the Inventurus Knowledge Solutions IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
concord biotech limited stock

CONCORD BIOTECH LIMITED Share Price

2111.4 -31.05 (-1.44%)
Dec 13 2024 03:30 PM Pharmaceuticals NSE: CONCORDBIO

CONCORD BIOTECH LIMITED Share Price Update

As of the latest trading session, CONCORD BIOTECH LIMITED share price is currently at 2111.4, which is down by -31.05 from its previous closing. Today, the stock has fluctuated between 2095.80 and 2145.00. Over the past year, CONCORD BIOTECH LIMITED has achieved a return of 59.68 %. In the last month alone, the return has been 13.89 %. Read More...

CONCORD BIOTECH LIMITED Performance

Day Range

Low2095.80 High2145.00
2111.40

52 Week Range

Low 1289.00 High 2664.00
2111.40

CONCORD BIOTECH LIMITED Share Price

18060

543960

CONCORDBIO

img img img img
No Data Available

Open Price

2139.85

Prev. Close

2142.45

Volume (Shares)

30840.00

Total traded value

651.15

Upper Circuit

2570.90

Lower Circuit

1714.00

Note: The current prices & values are delayed, Login to your account for live updates.

CONCORD BIOTECH LIMITED Fundamentals


(Standalone)

Market Cap (Cr) 22088.66
PE Ratio (TTM) 67.30
Book Value / Share 152.04
Beta 0.56
ROE 21.63%
EPS (TTM) 31.42
Dividend Yield 0.41%
Net Profit Qtr (Cr) 98.70

CONCORD BIOTECH LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 310.18
Operating Expense 186.92
Net Profit 98.70
Net Profit Margin (%) 31.82
Earnings Per Share (EPS) 9.43
EBITDA 146.70
Effective Tax Rate (%) 25.95
Particulars JUN 2024 (Values in Cr)
Revenue 215.80
Operating Expense 147.94
Net Profit 58.24
Net Profit Margin (%) 26.98
Earnings Per Share (EPS) 5.57
EBITDA 91.59
Effective Tax Rate (%) 25.49
Particulars MAR 2024 (Values in Cr)
Revenue 318.97
Operating Expense 198.86
Net Profit 97.21
Net Profit Margin (%) 30.47
Earnings Per Share (EPS) 9.29
EBITDA 145.10
Effective Tax Rate (%) 25.74
Particulars DEC 2023 (Values in Cr)
Revenue 240.80
Operating Expense 148.90
Net Profit 74.55
Net Profit Margin (%) 30.95
Earnings Per Share (EPS) 7.13
EBITDA 114.12
Effective Tax Rate (%) 25.50
Particulars SEP 2023 (Values in Cr)
Revenue 262.35
Operating Expense 157.29
Net Profit 84.49
Net Profit Margin (%) 32.20
Earnings Per Share (EPS) 8.08
EBITDA 127.32
Effective Tax Rate (%) 25.34
Particulars MAR 2024 (Values in Cr)
Revenue 1016.94
Operating Expense 641.52
Net Profit 304.73
Net Profit Margin (%) 29.96
Earnings Per Share (EPS) 29.13
EBITDA 465.33
Effective Tax Rate (%) 25.52
Particulars MAR 2023 (Values in Cr)
Revenue 853.17
Operating Expense 568.42
Net Profit 238.13
Net Profit Margin (%) 27.91
Earnings Per Share (EPS) 22.76
EBITDA 378.59
Effective Tax Rate (%) 25.59
Particulars MAR 2022 (Values in Cr)
Revenue 712.93
Operating Expense 495.19
Net Profit 178.57
Net Profit Margin (%) 25.04
Earnings Per Share (EPS) 187.76
EBITDA 296.69
Effective Tax Rate (%) 25.95
Particulars MAR 2021 (Values in Cr)
Revenue 616.94
Operating Expense 317.59
Net Profit 235.33
Net Profit Margin (%) 38.14
Earnings Per Share (EPS) 247.40
EBITDA 341.36
Effective Tax Rate (%) 24.85
Particulars MAR 2024 (Values in Cr)
Book Value / Share 145.93
ROE % 21.88
ROCE % 29.05
Total Debt to Total Equity 0.01
EBITDA Margin 46.15
Particulars MAR 2023 (Values in Cr)
Book Value / Share 123.31
ROE % 20.06
ROCE % 26.27
Total Debt to Total Equity 0.04
EBITDA Margin 44.68
Particulars MAR 2022 (Values in Cr)
Book Value / Share 1159.99
ROE % 16.64
ROCE % 21.59
Total Debt to Total Equity 0.07
EBITDA Margin 41.20
Particulars MAR 2021 (Values in Cr)
Book Value / Share 1050.80
ROE % 26.60
ROCE % 32.85
Total Debt to Total Equity 0.08
EBITDA Margin 55.42
Particulars MAR 2020 (Values in Cr)
Book Value / Share 809.87
ROE % 19.69
ROCE % 23.23
Total Debt to Total Equity 0.07
EBITDA Margin 41.50
Particulars MAR 2024 (Values in Cr)
Book Value / Share 145.80
ROE % 21.63
ROCE % 28.81
Total Debt to Total Equity 0.01
EBITDA Margin 45.82
Particulars MAR 2023 (Values in Cr)
Book Value / Share 123.50
ROE % 19.85
ROCE % 26.05
Total Debt to Total Equity 0.04
EBITDA Margin 44.45
Particulars MAR 2022 (Values in Cr)
Book Value / Share 1164.13
ROE % 16.95
ROCE % 21.86
Total Debt to Total Equity 0.07
EBITDA Margin 41.71
Particulars MAR 2021 (Values in Cr)
Book Value / Share 1051.11
ROE % 26.59
ROCE % 32.82
Total Debt to Total Equity 0.08
EBITDA Margin 55.39
Particulars MAR 2020 (Values in Cr)
Book Value / Share 809.71
ROE % 20.86
ROCE % 25.21
Total Debt to Total Equity 0.04
EBITDA Margin 41.47
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 47.02
Total Assets 1700.70
Total Liabilities 1700.70
Total Equity 1526.64
Share Outstanding 104616204
Price to Book Ratio 10.44
Return on Assets (%) 18.11
Return on Capital (%) 20.1
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 43.44
Total Assets 1513.98
Total Liabilities 1513.98
Total Equity 1290.00
Share Outstanding 104616204
Price to Book Ratio 0.00
Return on Assets (%) 15.85
Return on Capital (%) 18.17
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 88.93
Total Assets 1312.79
Total Liabilities 1312.79
Total Equity 1103.22
Share Outstanding 9510564
Price to Book Ratio 0.00
Return on Assets (%) 13.32
Return on Capital (%) 15.03
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 2.58
Total Assets 940.72
Total Liabilities 940.72
Total Equity 770.23
Share Outstanding 9510564
Price to Book Ratio 0.00
Return on Assets (%) 17.97
Return on Capital (%) 20.99
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 43.44
Total Assets 1514.64
Total Liabilities 1514.64
Total Equity 1291.98
Share Outstanding 104616204
Price to Book Ratio 0.00
Return on Assets (%) 15.72
Return on Capital (%) 18
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 88.93
Total Assets 1313.45
Total Liabilities 1313.45
Total Equity 1107.16
Share Outstanding 9510564
Price to Book Ratio 0.00
Return on Assets (%) 13.59
Return on Capital (%) 15.29
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 60.81
Total Assets 1182.84
Total Liabilities 1182.84
Total Equity 999.67
Share Outstanding 9510564
Price to Book Ratio 0.00
Return on Assets (%) 19.89
Return on Capital (%) 21.67
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 2.58
Total Assets 940.57
Total Liabilities 940.57
Total Equity 770.08
Share Outstanding 9510564
Price to Book Ratio 0.00
Return on Assets (%) 17.96
Return on Capital (%) 20.97
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 3.82
Total Assets 763.29
Total Liabilities 763.29
Total Equity 682.50
Share Outstanding 9510564
Price to Book Ratio 0.00
Return on Assets (%) 15.51
Return on Capital (%) 17.35
Particulars MAR 2024 (Values in Cr)
Net Income 412.56
Cash from Operations 368.81
Cash from Investing -154.60
Cash from Financing -99.21
Net change in Cash 11.64
Free Cash Flow 454.50
Particulars MAR 2023 (Values in Cr)
Net Income 322.01
Cash from Operations 316.27
Cash from Investing -157.95
Cash from Financing -85.21
Net change in Cash 2.83
Free Cash Flow 461.36
Particulars MAR 2022 (Values in Cr)
Net Income 237.51
Cash from Operations 268.25
Cash from Investing -111.78
Cash from Financing -100.16
Net change in Cash -4.47
Free Cash Flow 423.76
Particulars MAR 2020 (Values in Cr)
Net Income 213.63
Cash from Operations 204.19
Cash from Investing -113.92
Cash from Financing -42.51
Net change in Cash -1.35
Free Cash Flow 204.19
Particulars MAR 2024 (Values in Cr)
Net Income 409.19
Cash from Operations 368.81
Cash from Investing -154.60
Cash from Financing -99.21
Net change in Cash 11.64
Free Cash Flow 454.50
Particulars MAR 2023 (Values in Cr)
Net Income 320.05
Cash from Operations 316.27
Cash from Investing -157.95
Cash from Financing -85.21
Net change in Cash 2.83
Free Cash Flow 461.36
Particulars MAR 2022 (Values in Cr)
Net Income 241.15
Cash from Operations 268.25
Cash from Investing -111.78
Cash from Financing -100.16
Net change in Cash -4.47
Free Cash Flow 423.76
Particulars MAR 2021 (Values in Cr)
Net Income 313.16
Cash from Operations 241.98
Cash from Investing -195.20
Cash from Financing 31.12
Net change in Cash 2.73
Free Cash Flow 446.16
Particulars MAR 2020 (Values in Cr)
Net Income 213.48
Cash from Operations 204.04
Cash from Investing -113.77
Cash from Financing -42.51
Net change in Cash -1.35
Free Cash Flow 204.04
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 64.13 36.86 3.50 491.45 37.54 / 77.70
BLISS GVS PHARMA LTD 175.85 22.01 1.83 1852.87 92.25 / 179.65
CIPLA LTD 1447.35 25.32 4.12 116889.80 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 403.70 140.17 4.09 1188.13 145.00 / 440.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 64.13 55.77 10.90 491.45 37.54 / 77.70
AMRUTAJAN HEALTH LTD 749.90 45.61 7.28 2168.01 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6603.60 128.25 24.30 16509.00 4050.15 / 8139.85
BLISS GVS PHARMA LTD 175.85 22.93 1.80 1852.87 92.25 / 179.65

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 2136.30
  • 26 Days 2050.60
  • 10 Days 2142.90
  • 50 Days 2010.40
  • 12 Days 2133.10
  • 100 Days 1915.50
  • 20 Days 2082.10
  • 200 Days 1492.80
2159.48
PIVOT
First Resistance 2188.97
Second Resistance 2235.48
Third Resistance 2264.97
First Support 2112.97
Second Support 2083.48
Third Support 2036.97
RSI 55.40
MACD 82.43
Commodity Channel Index (CCI) 33.37
ADX 64.24
Williams % R -52.16

Over 1 Month

down

13.89

Over 3 Months

down

1.54

Over 6 Months

down

46.14

Over 1 Year

down

59.68

Over 3 Years

down

0.00

Over 5 Years

down

0.00

CONCORD BIOTECH LIMITED Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

CONCORD BIOTECH LIMITED Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
37.93
Promoter Holdings
44.08
FII
8.09
DII
9.88
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Sudhir Vaid Shareholding of Promoter and Promoter Group 3.0169524E7 28.84
Manju Vaid Shareholding of Promoter and Promoter Group 9987384.0 9.55
Aryavir Jhunjhunwala Discretionary Trust Public Shareholding 8399754.0 8.03
Aryaman Jhunjhunwala Discretionary Trust Public Shareholding 8399754.0 8.03
Nishtha Jhunjhunwala Discretionary Trust Public Shareholding 8399732.0 8.03
Sudman Consultants Llp Shareholding of Promoter and Promoter Group 4752000.0 4.54
Government Pension Fund Global Public Shareholding 2683394.0 2.56
1575773 Ontario Inc Public Shareholding 2092325.0 2.0
Amal N Parikh Public Shareholding 2023219.0 1.93
Max Life Insurance Company Limited A/c Reversionary Bonus Participating - Equity Public Shareholding 2002009.0 1.91
Tata Aia Life Insurance Co Ltd Unit Linked Multi Cap Fund Public Shareholding 1980578.0 1.89
Ravindra Raichand Dharamshi Public Shareholding 1606432.0 1.54
Chanakya Corporate Services Private Limited Public Shareholding 1163833.0 1.11
Invesco India Flexi Cap Fund Public Shareholding 1089185.0 1.04
Hsbc Small Cap Fund Public Shareholding 1067966.0 1.02
Ankur Sudhir Vaid Shareholding of Promoter and Promoter Group 586520.0 0.56
Vaid Megha Ankur Shareholding of Promoter and Promoter Group 547008.0 0.52
Sonal Kumra Shareholding of Promoter and Promoter Group 73920.0 0.07

CONCORD BIOTECH LIMITED

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About CONCORD BIOTECH LIMITED

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by CONCORD BIOTECH LIMITED

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Concord Biotech Ltd?

Answer Field

The share price of Concord Biotech Ltd for NSE is ₹ 2111.4 and for BSE is ₹ 2100.

What is the Market Cap of Concord Biotech Ltd?

Answer Field

The market cap of Concord Biotech Ltd for NSE is ₹ 2,20,88.66 Cr. and for BSE is ₹ 2,19,69.40 Cr. as of now.

What is the 52 Week High and Low of Concord Biotech Ltd?

Answer Field

The 52 Week High and Low of Concord Biotech Ltd for NSE is ₹ 2664.00 and ₹ 1313.00 and for BSE is ₹ 2658.00 and ₹ 1277.75.

How to Buy Concord Biotech Ltd share?

Answer Field

You can trade in Concord Biotech Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Concord Biotech Ltd?

Answer Field

The 1 year returns on the stock has been 59.68%.

What is the Current Share Price of Concord Biotech Ltd?

Answer Field

Concord Biotech Ltd share price is for NSE ₹ 2111.4 & for BSE ₹ 2100 as on Dec 13 2024 03:30 PM.

What is the Market Cap of Concord Biotech Ltd Share?

Answer Field

The market cap of Concord Biotech Ltd for NSE ₹ 2,20,88.66 & for BSE ₹ 2,19,69.40 as on Dec 13 2024 03:30 PM.

What is the P/E Ratio of Concord Biotech Ltd Share?

Answer Field

As on Dec 13 2024 03:30 PM the price-to-earnings (PE) ratio for Concord Biotech Ltd share is 67.30.

What is the PB ratio of Concord Biotech Ltd Share?

Answer Field

As on Dec 13 2024 03:30 PM, the price-to-book (PB) ratio for Concord Biotech Ltd share is 152.04.

How to Buy Concord Biotech Ltd Share?

Answer Field

You can trade in Concord Biotech Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Concord Biotech Ltd Share on Bajaj Broking App?

Answer Field

To buy Concord Biotech Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Concord Biotech Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader